Le Lézard
Classified in: Health
Subject: DIS

Dr. Ashley Shayter Selected Act Early Ambassador of Michigan


The Autism Alliance of Michigan (AAoM) is pleased to announce that Dr. Ashley Shayter, PhD, LBA, BCBA-D, CBIS, Policy Manager for Statewide Education & Outreach, has been selected as CDC's Act Early Ambassador to Michigan.

SOUTHFIELD, Mich., Nov. 3, 2022 /PRNewswire-PRWeb/ -- The Autism Alliance of Michigan (AAoM) is pleased to announce that Dr. Ashley Shayter, PhD, LBA, BCBA-D, CBIS, Policy Manager for Statewide Education & Outreach, has been selected as CDC's Act Early Ambassador to Michigan.

Act Early Ambassadors work with CDC's Learn the Signs. Act Early. program to improve early identification of developmental delays and disabilities so that children and their families can access needed services as early as possible.

"This is such a significant opportunity for AAoM and our state, said Colleen Allen, Ph.D., President and CEO of AAoM. Reducing the age of diagnosis and access to critical services is one of our major strategic initiatives over the next 10 years. The Learn the Signs. Act Early. Campaign is perfectly aligned with this work. Dr. Shayter's role as Ambassador will allow us to connect with national experts, colleagues in other states addressing this priority, and resources to share with stakeholders".

Since 2011, professionals with medical, child development, developmental disability, special education, and early intervention expertise have been selected to serve as a state or territorial point-of-contact for the national Learn the Signs. Act Early. program. The ambassador supports the work of Act Early Teams and other Michigan-specific initiatives to improve early identification of developmental delay and disability; and promote the adoption and integration of Learn the Signs. Act Early. resources into systems that serve young children and their families.

"I'm very excited to be the CDC's Act Early Ambassador for Michigan! Empowering parents with tools to watch their child grow and thrive is so important, says Dr. Ashley Shayter. We know that early intervention is key to maximizing long-term benefits. I hope my work as the Act Early Ambassador will encourage everyone who interacts with young children?from families to healthcare organizations to educators?to use the Learn the Signs. Act Early. materials and resources so we can ensure a bright and successful future for Michigan's children."

Click here to read more about CDC's Act Early Ambassadors.

About Autism Alliance of Michigan
Since 2009, The Autism Alliance of Michigan (AAoM) has led collaborative efforts across the state that improve the quality of life for individuals with autism through education, comprehensive services, community awareness, inclusion efforts and coordinated advocacy across their lifespan. AAoM is the trusted ally and partner for thousands of families.? An AAoM navigator can be reached at 877-463-2266 (AAOM) or email at [email protected]. For information on events, resources and donations, or for more information on the Watch Me Grow program, please visit autismallianceofmichigan.org.

# # #

Media Contact

Kristi Jackson, Autism Alliance of Michigan, 2489156675, [email protected]

LinkedIn

 

SOURCE Autism Alliance of Michigan


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: